# A 6-Part Study In Healthy Volunteers To Evaluate Safety, Tolerability and Uptake Of MEDI7219 in the Body When Given as Single and Multiple Doses

> **NCT03362593** · PHASE1 · TERMINATED · sponsor: **MedImmune LLC** · enrollment: 186 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** MEDI7219
- **DRUG:** Placebo
- **DRUG:** Formulation without Active Drug

## Key facts

- **NCT ID:** NCT03362593
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-12-04
- **Primary completion:** 2020-05-11
- **Final completion:** 2020-05-11
- **Target enrollment:** 186 (ACTUAL)
- **Why stopped:** The program is canceled due to company strategic reasons.
- **Last updated:** 2020-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03362593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03362593, "A 6-Part Study In Healthy Volunteers To Evaluate Safety, Tolerability and Uptake Of MEDI7219 in the Body When Given as Single and Multiple Doses". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03362593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*